Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells.

Dong X, Yu LG, Sun R, Cheng YN, Cao H, Yang KM, Dong YN, Wu Y, Guo XL.

J Cell Biochem. 2013 Jan;114(1):174-82. doi: 10.1002/jcb.24315.

PMID:
22887358
2.

Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.

Bruder-Nascimento T, Chinnasamy P, Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC, Sibinga NE.

J Mol Cell Cardiol. 2014 Jan;66:18-26.

3.

Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.

Moraes JA, Frony AC, Dias AM, Renovato-Martins M, Rodrigues G, Marcinkiewicz C, Assreuy J, Barja-Fidalgo C.

Atherosclerosis. 2015 Dec;243(2):477-85. doi: 10.1016/j.atherosclerosis.2015.09.026. Epub 2015 Sep 25.

4.

PPARδ coordinates angiotensin II-induced senescence in vascular smooth muscle cells through PTEN-mediated inhibition of superoxide generation.

Kim HJ, Ham SA, Kim MY, Hwang JS, Lee H, Kang ES, Yoo T, Woo IS, Yabe-Nishimura C, Paek KS, Kim JH, Seo HG.

J Biol Chem. 2011 Dec 30;286(52):44585-93. doi: 10.1074/jbc.M111.222562. Epub 2011 Nov 9.

5.

Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells.

Louis S, Saward L, Zahradka P.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H746-56. doi: 10.1152/ajpheart.00431.2010. Epub 2011 May 27.

6.

Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.

Pei X, Li X, Chen H, Han Y, Fan Y.

DNA Cell Biol. 2016 Aug;35(8):426-33. doi: 10.1089/dna.2016.3262. Epub 2016 Apr 11.

PMID:
27064837
7.

PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.

Ji Y, Liu J, Wang Z, Liu N, Gou W.

Lab Invest. 2009 Aug;89(8):887-902. doi: 10.1038/labinvest.2009.45. Epub 2009 May 18.

8.

Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.

Pu Q, Zhuang D, Thakran S, Hassid A.

Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H101-8. doi: 10.1152/ajpheart.00342.2010. Epub 2010 Oct 29.

9.

Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.

Cheng JF, Ni GH, Chen MF, Li YJ, Wang YJ, Wang CL, Yuan Q, Shi RZ, Hu CP, Yang TL.

Vascul Pharmacol. 2011 Jul-Sep;55(1-3):34-41. doi: 10.1016/j.vph.2011.04.003. Epub 2011 May 6.

PMID:
21586339
10.

Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.

Ren L, Liu N, Zhi H, Li Y, Li Y, Tang R, Sheng Z.

Cardiovasc Diabetol. 2011 Jan 26;10:10. doi: 10.1186/1475-2840-10-10.

11.

Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells.

Jin W, Reddy MA, Chen Z, Putta S, Lanting L, Kato M, Park JT, Chandra M, Wang C, Tangirala RK, Natarajan R.

J Biol Chem. 2012 May 4;287(19):15672-83. doi: 10.1074/jbc.M111.322669. Epub 2012 Mar 19.

12.

The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.

Wu Y, Nakagawa S, Takahashi H, Kawabata Y, Suzuki E, Uehara Y.

Hypertens Res. 2016 May;39(5):295-301. doi: 10.1038/hr.2015.154. Epub 2016 Jan 14.

PMID:
26763849
13.

Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.

Nagayama K, Kyotani Y, Zhao J, Ito S, Ozawa K, Bolstad FA, Yoshizumi M.

PLoS One. 2015 Sep 17;10(9):e0137960. doi: 10.1371/journal.pone.0137960. eCollection 2015.

14.

Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.

Mugabe BE, Yaghini FA, Song CY, Buharalioglu CK, Waters CM, Malik KU.

J Pharmacol Exp Ther. 2010 Jan;332(1):116-24. doi: 10.1124/jpet.109.157552. Epub 2009 Oct 1. Erratum in: J Pharmacol Exp Ther. 2010 Nov;335(2):516-7.

16.

GSTpi protects against angiotensin II-induced proliferation and migration of vascular smooth muscle cells by preventing signal transducer and activator of transcription 3 activation.

Chen D, Liu J, Rui B, Gao M, Zhao N, Sun S, Bi A, Yang T, Guo Y, Yin Z, Luo L.

Biochim Biophys Acta. 2014 Feb;1843(2):454-63. doi: 10.1016/j.bbamcr.2013.11.024. Epub 2013 Dec 7.

17.

B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.

Hsu JH, Liou SF, Yang SN, Wu BN, Dai ZK, Chen IJ, Yeh JL, Wu JR.

Pediatr Pulmonol. 2014 Aug;49(8):734-44. doi: 10.1002/ppul.22904. Epub 2013 Oct 25.

PMID:
24167111
18.

Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.

Hayabuchi Y, Nakaya Y, Yasui S, Mawatari K, Mori K, Suzuki M, Kagami S.

J Mol Cell Cardiol. 2006 Dec;41(6):972-9. Epub 2006 Aug 17.

PMID:
16919291
19.

Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation.

Shen YJ, Zhu XX, Yang X, Jin B, Lu JJ, Ding B, Ding ZS, Chen SH.

J Nat Med. 2014 Jul;68(3):623-9. doi: 10.1007/s11418-014-0825-0. Epub 2014 Mar 5.

PMID:
24595849

Supplemental Content

Support Center